At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
OZEM Roundhill GLP-1 & Weight Loss ETF
Post-Mkt 10-16 19:44:19 EDT
29.25
-0.29
-1.00%
盘后29.20
-0.05-0.16%
19:30 EDT
High29.55Low29.24Vol5.15K
Open29.55D1 Closing29.54Amplitude1.07%
Mkt Cap54.69MTradable Cap54.69MTotal Shares1.87M
T/O151.37KT/O Rate0.28%Tradable Shares1.87M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

NYSE Most Active Issues
Dow Jones  ·  05:44
NYSE Most Active Issues
Eli Lilly & Co Reports 19.9% Stake in Trex Bio as of Oct 13, 2026 - SEC Filing
THOMSON REUTERS  ·  04:21
Eli Lilly & Co Reports 19.9% Stake in Trex Bio as of Oct 13, 2026 - SEC Filing
Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market
Dow Jones  ·  00:03
Novo Nordisk A/S Series B Stock Falls Friday, Underperforms Market
Breakingviews-China Biotech's Ingenuity Extends to Dealmaking
Reuters  ·  10-16 20:00
Breakingviews-China Biotech's Ingenuity Extends to Dealmaking
Eli Lilly's Weight-Loss Pill Wins EU Drug Regulator's Backing
Reuters  ·  10-16 19:53
Eli Lilly's Weight-Loss Pill Wins EU Drug Regulator's Backing
Lilly's Foundayo Gets Positive EU Recommendation for Weight Management, Diabetes
MT Newswires Live  ·  10-16 19:13
Lilly's Foundayo Gets Positive EU Recommendation for Weight Management, Diabetes
Eli Lilly (LLY) Shares In Focus After Omvoh Shows Deep Remission In Crohn’s
Simply Wall St.  ·  10-16 18:32
Eli Lilly (LLY) Shares In Focus After Omvoh Shows Deep Remission In Crohn’s
Ema: New Oral Glp-1 Medicine for Weight Management and Type 2 Diabetes
THOMSON REUTERS  ·  10-16 18:01
Ema: New Oral Glp-1 Medicine for Weight Management and Type 2 Diabetes
Viking Therapeutics Initiated at Buy by UBS
Dow Jones  ·  10-16 06:55
Viking Therapeutics Initiated at Buy by UBS
Eli Lilly Stock Nears $1,292 All-Time High as Technicals Point to Potential New Record
TradingKey  ·  10-16 02:52
Eli Lilly Stock Nears $1,292 All-Time High as Technicals Point to Potential New Record
Big Pharma Stocks Near All-Time Highs as Tech Selloff Pushes Investors Toward Safer Bets
Dow Jones  ·  10-16 02:25
Big Pharma Stocks Near All-Time Highs as Tech Selloff Pushes Investors Toward Safer Bets
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
TradingKey  ·  10-16 02:15
Novo Nordisk A/S Stock (NVO) Moved Up by 3.38% on Oct 15: What Investors Need To Know
Lilly Targets KRAS G12C in Colorectal Cancer With New Phase 2 Trial
TIPRANKS  ·  10-16 00:31
Lilly Targets KRAS G12C in Colorectal Cancer With New Phase 2 Trial
Healthcare Stocks Rally as Investors Seek Safety Amid Tech Debt Worries
Reuters  ·  10-15 23:46
Healthcare Stocks Rally as Investors Seek Safety Amid Tech Debt Worries
Moderately bullish activity in Novo Nordisk with shares up 2.9%
TIPRANKS  ·  10-15 22:35
Moderately bullish activity in Novo Nordisk with shares up 2.9%
Eli Lilly and Company Publishes Update to Financial Calendar
Reuters  ·  10-15 22:02
Eli Lilly and Company Publishes Update to Financial Calendar
Eli Lilly and Co Stock (LLY) Opened Up by 3.50% on Oct 15: Drivers Behind the Movement
TradingKey  ·  10-15 21:47
Eli Lilly and Co Stock (LLY) Opened Up by 3.50% on Oct 15: Drivers Behind the Movement
Eli Lilly’s Omvoh Achieves Comprehensive Disease Control in 27.7% of Ulcerative Colitis Patients at One Year
Reuters  ·  10-15 20:07
Eli Lilly’s Omvoh Achieves Comprehensive Disease Control in 27.7% of Ulcerative Colitis Patients at One Year
Eli Lilly - 20.4% of Omvoh-Treated Crohn's Disease Patients Achieve Corticosteroid-Free Deep Remission at One Year
THOMSON REUTERS  ·  10-15 20:00
Eli Lilly - 20.4% of Omvoh-Treated Crohn's Disease Patients Achieve Corticosteroid-Free Deep Remission at One Year
Adlai Nortye enters CTCSAs with Eli Lilly, Merck KGaA for cetuximab
TIPRANKS  ·  10-15 19:10
Adlai Nortye enters CTCSAs with Eli Lilly, Merck KGaA for cetuximab

Introduction

Company Name.
Roundhill GLP-1 & Weight Loss ETF
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Issue price:
--